PSRC Abstract Supplement construct was placed. Post-operatively, animals were followed for 6 months, at which time CT imaging and micro-CT/histology of regenerated bone across the defects was evaluated.
CONCLUSION:
The described model of craniofacial bone reconstruction utilizing 3D printed, defect-specific bone regeneration templates has broad clinical applicability. Ultimately, insights from this model may realize the possibility of reconstructing bony defects of any size, shape, and thickness by harnessing the power of 3D printing and autologous bone stem cell seeding. Additionally, the described technique may enable critical scale-up capability of autologous cell populations across tissue types other than bone for use in post-traumatic and oncologic reconstruction. 
METHODS:
A retrospective review of medical record data and dental images was performed for all consecutive neonates (<1 year old) treated with this technique at a single institution from 2004-2014.
RESULTS:
A total of 100 consecutive patients (male = 50, 50%) treated by two-pin trans-facial mandibular distraction were identified, including both those treated primarily (n = 68), and secondarily with MDO following initial tracheostomy (n = 32). Peri-operative complications requiring unplanned surgical revision (n = 14, 14%) included hardware failure (n = 8) and early consolidation (n = 6). Significant long-term complications included limited mouth opening (n=2), marginal mandibular nerve weakness (n=1), and TMJ ankylosis (n=2, both of whom were syndromic, Catel-Manzke and Cornelia de Lange). No patients required scar revisions.
CONCLUSION:
The two-pin trans-facial technique for minimal-dissection external MDO is an effective tool for correction of severe airway obstruction in neonates with PRS, with favorable long-term outcomes and complication profile compared to traditional MDO. This technique has favorable or equivocal results for feeding and airway obstruction, measured by improved sleep studies or by tracheostomy avoidance.
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